Christophe Bonneville

Chief Executive Officer & Co-Founder Dillico

Seminars

Tuesday 21st July 2026
Bridging Innovation & Compliance: Continuous mRNA-LNP Manufacturing Without Reinventing GMP
2:00 pm
  • Targeted Innovation Where it Matters: Semi-continuous IVT to become scale-up free
  • Showcasing continuous manufacturing built on GMP-ready downstream platforms
  • Process modeling enabling optimized recipes and faster development towards a wide-range of indications and modalities

Christophe Bonneville